NYSE notifies Enzo Biochem not in compliance with certain requirements

Enzo Biochem (ENZ) announced that it was notified by the New York Stock Exchange that it is not in compliance with certain sections of the NYSE Listed Company Manual because its 30 trading-day average market capitalization was less than $50M and its last reported stockholder’s equity as of October 31, was less than $50M and the average closing price of the Company’s Common Stock was less than $1.00 over a consecutive 30 trading-day period. The Company has a period of 18 months to cure the market capitalization and stockholder’s equity deficiencies and a period of six months to cure the average closing stock price deficiency. The notice does not result in the immediate delisting of the Common Stock.